| Literature DB >> 28842327 |
Hong Liu1, Zhenzhen Wang2, Yi Li3, Gongqi Yu4, Xi'an Fu5, Chuan Wang4, Wenting Liu6, Yongxiang Yu7, Fangfang Bao4, Astrid Irwanto6, Jian Liu7, Tongsheng Chu7, Anand Kumar Andiappan8, Sebastian Maurer-Stroh9, Vachiranee Limviphuvadh10, Honglei Wang5, Zihao Mi4, Yonghu Sun4, Lele Sun4, Ling Wang6, Chaolong Wang11, Jiabao You7, Jinghui Li7, Jia Nee Foo6, Herty Liany6, Wee Yang Meah6, Guiye Niu2, Zhenhua Yue5, Qing Zhao5, Na Wang5, Meiwen Yu12, Wenjun Yu13, Xiujun Cheng5, Chiea Chuen Khor6, Kar Seng Sim6, Tin Aung14, Ningli Wang15, Deyun Wang16, Li Shi17, Yong Ning18, Zhongyi Zheng19, Rongde Yang20, Jinlan Li21, Jun Yang22, Liangbin Yan12, Jianping Shen12, Guocheng Zhang12, Shumin Chen7, Jianjun Liu6, Furen Zhang23.
Abstract
Although genome-wide association studies have greatly advanced our understanding of the contribution of common noncoding variants to leprosy susceptibility, protein-coding variants have not been systematically investigated. We carried out a three-stage genome-wide association study of protein-coding variants in Han Chinese, of whom were 7,048 leprosy patients and 14,398 were healthy control subjects. Seven coding variants of exome-wide significance were discovered, including two rare variants: rs145562243 in NCKIPSD (P = 1.71 × 10-9, odds ratio [OR] = 4.35) and rs149308743 in CARD9 (P = 2.09 × 10-8, OR = 4.75); three low-frequency variants: rs76418789 in IL23R (P = 1.03 × 10-10, OR = 1.36), rs146466242 in FLG (P = 3.39 × 10-12, OR = 1.45), and rs55882956 in TYK2 (P = 1.04 × 10-6, OR = 1.30); and two common variants: rs780668 in SLC29A3 (P = 2.17 × 10-9, OR = 1.14) and rs181206 in IL27 (P = 1.08 × 10-7, OR = 0.83). Discovered protein-coding variants, particularly low-frequency and rare ones, showed involvement of skin barrier and endocytosis/phagocytosis/autophagy, in addition to known innate and adaptive immunity, in the pathogenesis of leprosy, highlighting the merits of protein-coding variant studies for complex diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28842327 DOI: 10.1016/j.jid.2017.08.004
Source DB: PubMed Journal: J Invest Dermatol ISSN: 0022-202X Impact factor: 8.551